• Join
  • Login
  • Contact

Search abstracts

Standards of evidence for regulatory decision making

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Presentation
  • By: HEMMINGS, Robert (MHRA, Licensing Division, London, United Kingdom)
  • Co-author(s): Robert Hemmings: Licensing Division, MHRA, London, United Kingdom
  • Abstract:

    Regulators encourage early dialogue with companies planning strategies for global drug development, licensing and commercialisation.  That diagloue helps to define a path for the development, including standards for licensing, different methodological approaches in clinical trial design, conduct and analysis, and regulatory tools to support


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses